Companies: 10,795·Total market cap: $144.5T
Lixte Biotechnology Holdings, Inc.

Lixte Biotechnology Holdings, Inc.

LIXTNASDAQHealthcare● Active
$6.65
$-0.35(-5.00%)
Market Cap$82346285
P/E Ratio
52W High$7.5
52W Low$0.64
Overview

Lixte Biotechnology Holdings, Inc.(LIXT)股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · LIXT · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-1.13lixt eps ttm · lixt earnings per shareEarnings history
PE Ratio (TTM)lixt pe ratio ttm · lixt price to earningsPE Ratio deep dive
Revenue (TTM)0.00lixt revenue ttm · lixt annual revenueFull revenue history
Dividend Yield不分红does lixt pay dividends · lixt dividend yieldDividend history
Shares Outstanding48.4Mlixt shares outstanding · lixt floatShares outstanding history
Next EarningsTBAlixt earnings date · lixt next earningsEarnings history

财务快照

完整财报
FY 2025Revenue$0.00
202320242025
lixte biotechnology holdings, inc. revenue · lixt revenue 2025
FY 2025Net Income-$6.0M▼ 67.58% YoY
202320242025
lixte biotechnology holdings, inc. net income · lixt profit 2025
FY 2025EPS$-1.26▲ +20.75% YoY
202320242025
lixt eps · lixte biotechnology holdings, inc. earnings per share 2025
TTM:Revenue: $0.00Net Income: -$7.3MEPS: $-1.13View income statement →

股票表现

完整历史
1D-5.00%
1W-5.41%
1M+28.88%
3M+172.54%
YTD+69.21%
1Y+432.00%
5Y-77.07%

关于 Lixte Biotechnology Holdings, Inc.

CEOGeordan G. Pursglove
IPO DateOct 25, 2007
Employees2
CountryUS
Websitelixte.com

Lixte Biotechnology Holdings, Inc. is a drug discovery company focused on developing new treatments. It employs biomarker technology to identify crucial enzyme targets associated with serious, widespr…

what is lixte biotechnology holdings, inc. · lixt stock overview · lixte biotechnology holdings, inc. company profile · who is lixte biotechnology holdings, inc. ceo · lixt NASDAQ · lixte biotechnology holdings, inc. headquarters · lixte biotechnology holdings, inc. business segments

关于股票概览与关键数据

Lixte Biotechnology Holdings, Inc.(LIXT)是 Biotechnology 行业的 Healthcare 类公司,于 Oct 25, 2007 在 NASDAQ 上市。截至最近交易日,LIXT 股价为 $6.65,市值约为 $82.3M。过去12个月累计回报 +432.00%,年初至今回报 +69.21%。

2025 财年 Lixte Biotechnology Holdings, Inc. 营收 —。完整财务数据(营收历史、盈利、资产负债表)请使用上方标签页。

常见问题

截至最近一个交易日,Lixte Biotechnology Holdings, Inc.(LIXT)股价为 $6.65,在 NASDAQ 上市,52周区间为 $0.64 – $7.50。

LIXT 最新股价LIXT quote todaylive ticker 实时行情
数据来源:Financial Modeling Prep最后更新:Jun 9, 2026本内容不构成投资建议